Clarion News

Highlights in Precision Medicine from Virtual AACR 2020

SHARE:

Clarion congratulates the American Association for Cancer Research (AACR) on successfully adapting their annual meeting to an online platform. Part one of the 2020 AACR Virtual Meeting on April 27–28 was the largest cancer conference in history, attracting over 61,000 attendees from 140 countries. The conference was wide-ranging, providing diverse clinical trial updates, preclinical explorations of novel mechanisms, and discussions of critical topics (such as COVID-19 in cancer patients), and we look forward to part two on June 22–24, 2020. In the meantime, we present here selected highlights focused specifically on precision medicine:

Key Takeaways

  • New targeted therapies may make previously challenging mutations actionable
  • Liquid biopsies continue to advance across multiple applications
  • Big data enable improvements in mutation profiling
  • Precision immuno-oncology studies identify new biomarkers and targets

 

Click HERE to read the full perspectives for the 2020 AACR Virtual Meeting, Part 1 

Is Clarion the right place to advance your career?

Find out more about joining Clarion’s team of innovation advisors.

A life sciences strategy and organizational consultancy that collaborates with its clients to envision, craft and enable growth through innovation and leadership.